The median change in HCC tumor size between responders and nonresponders was statistically significant.
All articles by Randi Hernandez
Although the use of value pathways in oncology appeared to extend time to treatment failure, it did not appear to influence overall survival.
Researchers hypothesized that because prior studies have demonstrated that common drugs can affect the microbiome, these medications could also impact IO efficacy in HCC.
Even though older adults were prescribed second-line therapies less frequently than younger adults, patients had similar overall survival outcomes across age subgroups.